REFERENCES
1. Cui J, Li F, Shi ZL. Origin and evolution of pathogenic
coronaviruses. Nat Rev Microbiol. 2019;17(3):181-92.
2. Kaur N, Singh R, Dar Z, Bijarnia RK, Dhingra N, Kaur T. Genetic
comparison among various coronavirus strains for the identification of
potential vaccine targets of SARS-CoV2. Infect Genet Evol.
2021;89:104490.
3. Ng KW, Faulkner N, Cornish GH, Rosa A, Harvey R, Hussain S, et al.
Preexisting and de novo humoral immunity to SARS-CoV-2 in humans.
Science. 2020;370(6522):1339-43.
4. Anderson EM, Goodwin EC, Verma A, Arevalo CP, Bolton MJ, Weirick ME,
et al. Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2
infection but not associated with protection. Cell. 2021;184(7):1858-64
e10.
5. Lin CY, Wolf J, Brice DC, Sun Y, Locke M, Cherry S, et al.
Pre-existing humoral immunity to human common cold coronaviruses
negatively impacts the protective SARS-CoV-2 antibody response. Cell
Host Microbe. 2022;30(1):83-96 e4.
6. Wratil PR, Schmacke NA, Karakoc B, Dulovic A, Junker D, Becker M, et
al. Evidence for increased SARS-CoV-2 susceptibility and COVID-19
severity related to pre-existing immunity to seasonal coronaviruses.
Cell Rep. 2021;37(13):110169.
7. Swadling L, Diniz MO, Schmidt NM, Amin OE, Chandran A, Shaw E, et al.
Pre-existing polymerase-specific T cells expand in abortive seronegative
SARS-CoV-2. Nature. 2022;601(7891):110-7.
8. Kundu R, Narean JS, Wang L, Fenn J, Pillay T, Fernandez ND, et al.
Cross-reactive memory T cells associate with protection against
SARS-CoV-2 infection in COVID-19 contacts. Nat Commun. 2022;13(1):80.
9. Elko EA, Nelson GA, Mead HL, Kelley EJ, Carvalho ST, Sarbo NG, et al.
COVID-19 vaccination elicits an evolving, cross-reactive antibody
response to epitopes conserved with endemic coronavirus spike proteins.
Cell Rep. 2022;40(1):111022.
10. Geanes ES, LeMaster C, Fraley ER, Khanal S, McLennan R, Grundberg E,
et al. Cross-reactive antibodies elicited to conserved epitopes on
SARS-CoV-2 spike protein after infection and vaccination. Sci Rep.
2022;12(1):6496.
11. Crowley AR, Natarajan H, Hederman AP, Bobak CA, Weiner JA,
Wieland-Alter W, et al. Boosting of cross-reactive antibodies to endemic
coronaviruses by SARS-CoV-2 infection but not vaccination with
stabilized spike. Elife. 2022;11.
12. Amanat F, Thapa M, Lei T, Ahmed SMS, Adelsberg DC, Carreno JM, et
al. SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies
to NTD, RBD, and S2. Cell. 2021;184(15):3936-48 e10.
13. Aydillo T, Rombauts A, Stadlbauer D, Aslam S, Abelenda-Alonso G,
Escalera A, et al. Immunological imprinting of the antibody response in
COVID-19 patients. Nat Commun. 2021;12(1):3781.
14. Murray SM, Ansari AM, Frater J, Klenerman P, Dunachie S, Barnes E,
et al. The impact of pre-existing cross-reactive immunity on SARS-CoV-2
infection and vaccine responses. Nat Rev Immunol. 2023;23(5):304-16.
15. Heinz FX, Stiasny K. Distinguishing features of current COVID-19
vaccines: knowns and unknowns of antigen presentation and modes of
action. NPJ Vaccines. 2021;6(1):104.
16. Perera RA, Wang P, Gomaa MR, El-Shesheny R, Kandeil A, Bagato O, et
al. Seroepidemiology for MERS coronavirus using microneutralisation and
pseudoparticle virus neutralisation assays reveal a high prevalence of
antibody in dromedary camels in Egypt, June 2013. Euro Surveill.
2013;18(36):pii=20574.
17. Singh G, Abbad A, Kleiner G, Srivastava K, Gleason C, Group PS, et
al. The post-COVID-19 population has a high prevalence of cross-reactive
antibodies to spikes from all Orthocoronavirinae genera. mBio.
2023:e0225023.
18. Sauer MM, Tortorici MA, Park YJ, Walls AC, Homad L, Acton OJ, et al.
Structural basis for broad coronavirus neutralization. Nat Struct Mol
Biol. 2021;28(6):478-86.
19. Dacon C, Tucker C, Peng L, Lee CD, Lin TH, Yuan M, et al. Broadly
neutralizing antibodies target the coronavirus fusion peptide. Science.
2022;377(6607):728-35.
20. Song G, He WT, Callaghan S, Anzanello F, Huang D, Ricketts J, et al.
Cross-reactive serum and memory B-cell responses to spike protein in
SARS-CoV-2 and endemic coronavirus infection. Nat Commun.
2021;12(1):2938.
21. Zhou P, Song G, Liu H, Yuan M, He WT, Beutler N, et al. Broadly
neutralizing anti-S2 antibodies protect against all three human
betacoronaviruses that cause deadly disease. Immunity. 2023;56(3):669-86
e7.
22. Pinto D, Sauer MM, Czudnochowski N, Low JS, Tortorici MA, Housley
MP, et al. Broad betacoronavirus neutralization by a stem helix-specific
human antibody. Science. 2021;373(6559):1109-16.